1. Home
  2. SAGE vs CLDT Comparison

SAGE vs CLDT Comparison

Compare SAGE & CLDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAGE
  • CLDT
  • Stock Information
  • Founded
  • SAGE 2010
  • CLDT 2009
  • Country
  • SAGE United States
  • CLDT United States
  • Employees
  • SAGE N/A
  • CLDT N/A
  • Industry
  • SAGE Biotechnology: Pharmaceutical Preparations
  • CLDT Real Estate Investment Trusts
  • Sector
  • SAGE Health Care
  • CLDT Real Estate
  • Exchange
  • SAGE Nasdaq
  • CLDT Nasdaq
  • Market Cap
  • SAGE 462.2M
  • CLDT 450.5M
  • IPO Year
  • SAGE 2014
  • CLDT 2010
  • Fundamental
  • Price
  • SAGE $6.94
  • CLDT $8.80
  • Analyst Decision
  • SAGE Hold
  • CLDT Strong Buy
  • Analyst Count
  • SAGE 20
  • CLDT 2
  • Target Price
  • SAGE $11.39
  • CLDT $12.00
  • AVG Volume (30 Days)
  • SAGE 2.8M
  • CLDT 249.4K
  • Earning Date
  • SAGE 02-12-2025
  • CLDT 02-25-2025
  • Dividend Yield
  • SAGE N/A
  • CLDT 3.18%
  • EPS Growth
  • SAGE N/A
  • CLDT N/A
  • EPS
  • SAGE N/A
  • CLDT N/A
  • Revenue
  • SAGE $106,399,000.00
  • CLDT $313,268,000.00
  • Revenue This Year
  • SAGE N/A
  • CLDT N/A
  • Revenue Next Year
  • SAGE $122.32
  • CLDT $3.83
  • P/E Ratio
  • SAGE N/A
  • CLDT N/A
  • Revenue Growth
  • SAGE 837.60
  • CLDT 1.77
  • 52 Week Low
  • SAGE $4.62
  • CLDT $7.60
  • 52 Week High
  • SAGE $27.68
  • CLDT $11.10
  • Technical
  • Relative Strength Index (RSI)
  • SAGE 60.28
  • CLDT 44.26
  • Support Level
  • SAGE $6.75
  • CLDT $8.65
  • Resistance Level
  • SAGE $7.88
  • CLDT $8.91
  • Average True Range (ATR)
  • SAGE 0.38
  • CLDT 0.21
  • MACD
  • SAGE 0.13
  • CLDT 0.00
  • Stochastic Oscillator
  • SAGE 64.39
  • CLDT 65.97

About SAGE Sage Therapeutics Inc.

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.

About CLDT Chatham Lodging Trust (REIT) of Beneficial Interest

Chatham Lodging Trust is a U.S.-based real estate investment trust that invests in upscale extended-stay hotels. The firm operates across various states in the U.S., including California, New York, Texas, Florida, Minnesota, Massachusetts, and Pennsylvania among others. Substantially all of the company's assets are held and operated by its Operating Partnership, Chatham Lodging, LP. Chatham Lodging LP and its subsidiaries lease the overall company's hotels. The firm operates through a single segment because of the similar economic characteristics of its hotels. Chatham's revenue streams include Room, Food and beverage, and Other. Room comprises the majority of total revenue. Chatham's hotels operate under brands which include, Hilton, Marriott, and Hyatt.

Share on Social Networks: